276 related articles for article (PubMed ID: 31096719)
41. Regulation of chemokine activity by posttranslational modification.
Mortier A; Van Damme J; Proost P
Pharmacol Ther; 2008 Nov; 120(2):197-217. PubMed ID: 18793669
[TBL] [Abstract][Full Text] [Related]
42. CC-chemokine CCL15 expression and possible implications for the pathogenesis of IgE-related severe asthma.
Shimizu Y; Dobashi K
Mediators Inflamm; 2012; 2012():475253. PubMed ID: 23258953
[TBL] [Abstract][Full Text] [Related]
43. Inhibition of respiratory syncytial virus infection with the CC chemokine RANTES (CCL5).
Elliott MB; Tebbey PW; Pryharski KS; Scheuer CA; Laughlin TS; Hancock GE
J Med Virol; 2004 Jun; 73(2):300-8. PubMed ID: 15122808
[TBL] [Abstract][Full Text] [Related]
44. Expression, purification and in vitro functional reconstitution of the chemokine receptor CCR1.
Allen SJ; Ribeiro S; Horuk R; Handel TM
Protein Expr Purif; 2009 Jul; 66(1):73-81. PubMed ID: 19275940
[TBL] [Abstract][Full Text] [Related]
45. Synergy between proinflammatory ligands of G protein-coupled receptors in neutrophil activation and migration.
Gouwy M; Struyf S; Catusse J; Proost P; Van Damme J
J Leukoc Biol; 2004 Jul; 76(1):185-94. PubMed ID: 15075362
[TBL] [Abstract][Full Text] [Related]
46. Structural Insights into Molecular Recognition and Receptor Activation in Chemokine-Chemokine Receptor Complexes.
Urvas L; Kellenberger E
J Med Chem; 2023 Jun; 66(11):7070-7085. PubMed ID: 37212620
[TBL] [Abstract][Full Text] [Related]
47. The beta-chemokines CCL2 and CCL7 are two novel differentiation factors for midbrain dopaminergic precursors and neurons.
Edman LC; Mira H; Arenas E
Exp Cell Res; 2008 Jun; 314(10):2123-30. PubMed ID: 18420193
[TBL] [Abstract][Full Text] [Related]
48. Differential responsiveness to constitutive vs. inducible chemokines of immature and mature mouse dendritic cells.
Vecchi A; Massimiliano L; Ramponi S; Luini W; Bernasconi S; Bonecchi R; Allavena P; Parmentier M; Mantovani A; Sozzani S
J Leukoc Biol; 1999 Sep; 66(3):489-94. PubMed ID: 10496320
[TBL] [Abstract][Full Text] [Related]
49. Differential CCR1-mediated chemotaxis signaling induced by human CC chemokine HCC-4/CCL16 in HOS cells.
Kim IS; Jang SW; Sung HJ; Lee JS; Ko J
FEBS Lett; 2005 Nov; 579(27):6044-8. PubMed ID: 16226254
[TBL] [Abstract][Full Text] [Related]
50. Synergistic up-regulation of MCP-2/CCL8 activity is counteracted by chemokine cleavage, limiting its inflammatory and anti-tumoral effects.
Struyf S; Proost P; Vandercappellen J; Dempe S; Noyens B; Nelissen S; Gouwy M; Locati M; Opdenakker G; Dinsart C; Van Damme J
Eur J Immunol; 2009 Mar; 39(3):843-57. PubMed ID: 19224633
[TBL] [Abstract][Full Text] [Related]
51. Oncostatin M-induced and constitutive activation of the JAK2/STAT5/CIS pathway suppresses CCL1, but not CCL7 and CCL8, chemokine expression.
Hintzen C; Haan C; Tuckermann JP; Heinrich PC; Hermanns HM
J Immunol; 2008 Nov; 181(10):7341-9. PubMed ID: 18981157
[TBL] [Abstract][Full Text] [Related]
52. Different effects of the different natural CC chemokine receptor 2b ligands on beta-arrestin recruitment, Gαi signaling, and receptor internalization.
Berchiche YA; Gravel S; Pelletier ME; St-Onge G; Heveker N
Mol Pharmacol; 2011 Mar; 79(3):488-98. PubMed ID: 21088225
[TBL] [Abstract][Full Text] [Related]
53. Key determinants of selective binding and activation by the monocyte chemoattractant proteins at the chemokine receptor CCR2.
Huma ZE; Sanchez J; Lim HD; Bridgford JL; Huang C; Parker BJ; Pazhamalil JG; Porebski BT; Pfleger KDG; Lane JR; Canals M; Stone MJ
Sci Signal; 2017 May; 10(480):. PubMed ID: 28536301
[TBL] [Abstract][Full Text] [Related]
54. Inactivation of chemokine (C-C motif) receptor 1 (CCR1) suppresses colon cancer liver metastasis by blocking accumulation of immature myeloid cells in a mouse model.
Kitamura T; Fujishita T; Loetscher P; Revesz L; Hashida H; Kizaka-Kondoh S; Aoki M; Taketo MM
Proc Natl Acad Sci U S A; 2010 Jul; 107(29):13063-8. PubMed ID: 20616008
[TBL] [Abstract][Full Text] [Related]
55. Extracellular disulfide bridges serve different purposes in two homologous chemokine receptors, CCR1 and CCR5.
Rummel PC; Thiele S; Hansen LS; Petersen TP; Sparre-Ulrich AH; Ulven T; Rosenkilde MM
Mol Pharmacol; 2013 Sep; 84(3):335-45. PubMed ID: 23765404
[TBL] [Abstract][Full Text] [Related]
56. CCL15 Recruits Suppressive Monocytes to Facilitate Immune Escape and Disease Progression in Hepatocellular Carcinoma.
Liu LZ; Zhang Z; Zheng BH; Shi Y; Duan M; Ma LJ; Wang ZC; Dong LQ; Dong PP; Shi JY; Zhang S; Ding ZB; Ke AW; Cao Y; Zhang XM; Xi R; Zhou J; Fan J; Wang XY; Gao Q
Hepatology; 2019 Jan; 69(1):143-159. PubMed ID: 30070719
[TBL] [Abstract][Full Text] [Related]
57. Cellular Electrical Impedance as a Method to Decipher CCR7 Signalling and Biased Agonism.
Vanalken N; Boon K; Doijen J; Schols D; Van Loy T
Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012168
[TBL] [Abstract][Full Text] [Related]
58. Location bias contributes to functionally selective responses of biased CXCR3 agonists.
Eiger DS; Boldizsar N; Honeycutt CC; Gardner J; Kirchner S; Hicks C; Choi I; Pham U; Zheng K; Warman A; Smith JS; Zhang JY; Rajagopal S
Nat Commun; 2022 Oct; 13(1):5846. PubMed ID: 36195635
[TBL] [Abstract][Full Text] [Related]
59. CXC Chemokine Receptor 3 Alternative Splice Variants Selectively Activate Different Signaling Pathways.
Berchiche YA; Sakmar TP
Mol Pharmacol; 2016 Oct; 90(4):483-95. PubMed ID: 27512119
[TBL] [Abstract][Full Text] [Related]
60. C-X-C Motif Chemokine Receptor 3 Splice Variants Differentially Activate Beta-Arrestins to Regulate Downstream Signaling Pathways.
Smith JS; Alagesan P; Desai NK; Pack TF; Wu JH; Inoue A; Freedman NJ; Rajagopal S
Mol Pharmacol; 2017 Aug; 92(2):136-150. PubMed ID: 28559424
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
